Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pharm. care Esp ; 24(1): 20-32, feb. 15, 2022. graf
Artigo em Espanhol | IBECS | ID: ibc-204747

RESUMO

Introducción: La atención sociosanitaria es una evaluación multidimensional e interdisciplinar para mejorar la calidad de vida del paciente institucio-nalizado. El objetivo de este estudio fue describir y cuantificar las intervenciones realizadas por un farmacéutico al ingreso de pacientes en un centro sociosanitario (CSS). Método: Estudio unicéntrico y prospectivo de 20 meses de duración realizado en un CSS de 251 camas. Se incluyeron 3 modalidades de atención sociosanitaria (ancianos pernocta, centro terapéu-tico-ocupacional pernocta y gravemente afecta-dos). Los datos se obtuvieron de la historia clínica electrónica y se registraron variables relacionadas con el paciente (fecha nacimiento, sexo, insuficien-cia renal, índice de Charlson, registro de alergias) y con el tratamiento (número de fármacos prescritos al ingreso en el CSS e interacciones, número de fármacos monitorizables farmacocinéticamente, recomendaciones de farmacovigilancia y seguri-dad, problemas relacionados con los medicamen-tos (PRM) detectados y las adaptaciones a guía farmacoterapéutica). Para el análisis estadístico, se utilizó el programa SPSS. Resultados: Se incluyeron 172 ingresos, con una edad media de 78,4 años (DS: 17,7 años) y el 65,1% fueron mujeres. La media de fármacos prescritos por paciente fue de 9,5 (DS: 4,4). En el 51,7% de los pacientes se detectó al menos un PRM, con una media de 3,2 PRM/paciente. En el 64,5% de los in-gresos se realizaron adaptaciones a la guía farma-coterapéutica, con una media de 1,3 adaptaciones/paciente. Conclusiones: El farmacéutico realiza numerosas intervenciones en un CSS, como las adaptaciones a guía y la detección de PRM, resaltando la importan-cia de su presencia y su conciliación entre niveles asistenciales (AU)


Introduction: Social health care is a multidimen-sional and interdisciplinary evaluation to improve the quality of life of the institutionalized patient. The objective of this study was to describe and quantify the interventions carried out by a specialist pharmacist at the time of patients' admission in a nursing home (NH). Method: This is a single-centre and prospective study with a duration of 20 months made in a NH with 251 beds. 3 kinds of social-healthcare were included [old people that stay the night, therapeu-tic-occupational centre (stay the night) and severely affected]. Data were obtained from the electronic clinical records. Furthermore, variables related to the patient (birth date, gender, kidney failure, Char-lson index, allergies record) and to the treatment [number of drugs prescribed on admission in a NH and interactions, number of drugs that could be monitored thanks to the pharmacokinetics, security and pharmacovigilance recommendations, drug related problems (DRPs) detected and adaptations to pharmacotherapy guide] were recorded. The pro-gram SPSS was used for the statistical analysis.Results: 172 admissions were included, with an average age of 78.4 years (SD: 17.7 years). 65.1% of admissions were women. The average of drugs prescribed per patient was 9.5 (SD: 4.4). 51.7% of patients were detected with at least one DRP, with an average of 3.2 DRPs/patient. In 64.5% of admissions, adaptations to the pharmacotherapeu-tic guide were carried out, with an average of 1.3 adaptations/patient. Conclusions: In a NH, the pharmacist performs many interventions, such as adaptations to the guide, detection of DRPs and conciliation between levels of care (AU)


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Assistência Farmacêutica , Instalações de Saúde , Prescrições de Medicamentos/estatística & dados numéricos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Acesso a Medicamentos Essenciais e Tecnologias em Saúde , Estudos Prospectivos
2.
Farm. hosp ; 45(1): 3-9, ene.-feb. 2021. tab, graf
Artigo em Espanhol | IBECS | ID: ibc-202354

RESUMO

OBJETIVO: El objetivo del estudio es evaluar los resultados de la aplica-ción de la metodología Lean en el diseño de un modelo estandarizado de almacenaje de medicación en las unidades de hospitalización. MÉTODO: Estudio descriptivo y retrospectivo desarrollado entre septiembre de 2017 y enero de 2019 en un hospital de tercer nivel. Se creó un equipo multidisciplinar liderado por el Servicio de Farmacia. Se empleó la metodología Lean para establecer los elementos y criterios de organización e identificación que conformaron el modelo estandarizado de almacenaje de medicación. Se revisaron y cuantificaron los stocks de cada unidad de hospitalización, se consensuó la medicación con la supervisora de cada unidad y se estimó el impacto económico de la implantación del modelo estandarizado. Se diseñó y envió una encuesta para evaluar la satisfacción de enfermería con el nuevo modelo. RESULTADOS: El modelo estandarizado de almacenaje se aplicó en 20 unidades de enfermería y supuso una reducción global del 56,72% en el número de presentaciones de principios activos disponibles (5.688 versus2.462). Se disminuyó el número de presentaciones de principios activos de medicamentos de alto riesgo en un 40,73% (631 versus 374). La eliminación de este despilfarro supuso un ahorro económico de 25.357,98 (Euro). Se recibieron 58 respuestas a la encuesta de satisfacción del personal de enfermería (20,70% del total de encuestas enviadas), de las que un 22,40% correspondieron al turno fijo y 77,60% al turno rotativo. La media de la satisfacción global (valorada entre 1 y 10) fue de 5,79 ± 3,61. CONCLUSIONES: La aplicación de la metodología Lean es útil para la gestión de stocks de medicación de las unidades de hospitalización. La implantación del modelo estandarizado de almacenaje conlleva un ahorro económico y una reducción del número de presentaciones de principios activos y de medicamentos de alto riesgo. El personal de enfermería está conforme con la implantación del modelo, lo que nos plantea seguir en esta línea de mejora


OBJECTIVE: The objective of this study was to assess the results of applying Lean Methodology in the design of a standardized medication storage model in hospitalization departments. METHOD: Descriptive and retrospective study conducted between September 2017 and January 2019 in a tertiary level hospital. The Pharmacy Service led the creation of a multidisciplinary team. Lean Methodology was used to establish the components and organization and identification criteria that made up the standardized medication storage model. The stocks of each hospitalization department were reviewed and quantified, the final amount of stock needed was agreed with the supervisor of each department, and the economic impact of the implementation of the standardized medication model was assessed. A questionnaire was designed and sent to nursing staff to determine their level of satisfaction with the new model. RESULTS: The standardized medication storage model was scaled up to 20 nursing departments, leading to an overall reduction of 56.72% in the number of pharmaceutical dosage forms available (5,688 vs 2,462). The number of high-risk drugs was reduced by 40.73% (631 vs 374). This elimination of wastage achieved a saving of (Euro)25,357.98. A total of 58 nurses returned the questionnaires (20.70% of the total): 22.40% worked a fixed shift and 77.60% worked a rotating shift. The mean score on overall satisfaction was 5.79 ± 3.61 (scores ranged from 1 to 10). CONCLUSIONS: The application of Lean Methodology is very useful for the management of medication stocks in hospitalization departments. The implementation of a standardized medication storage model leads to economic savings and a marked reduction in the number of active ingredients and high-risk medications. The nursing staff were satisfied with the implementation of the model, suggesting that we should continue to pursue this effective line of action


Assuntos
Humanos , Armazenamento de Medicamentos/normas , Serviço de Farmácia Hospitalar/organização & administração , Conduta do Tratamento Medicamentoso/organização & administração , Boas Práticas de Dispensação , Qualidade da Assistência à Saúde/organização & administração , Valores de Referência , Erros de Medicação/prevenção & controle , Estudos Retrospectivos
3.
J Clin Pharm Ther ; 46(3): 724-730, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33368439

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Initial treatment recommendations of COVID-19 were based on the use of antimicrobial drugs and immunomodulators. Although information on drug interactions was available for other pathologies, there was little evidence in the treatment of COVID-19. The objective of this study was to analyse the potential drug-drug interactions (pDDIs) derived from the medication used in COVID-19 patients in the first pandemic wave and to evaluate the real consequences of such interactions in clinical practice. METHODS: Cohort, retrospective and single-centre study carried out in a third-level hospital. Adult patients, admitted with suspected COVID-19, that received at least one dose of hydroxychloroquine, lopinavir/ritonavir, interferon beta 1-b or tocilizumab and with any pDDIs according to "Liverpool Drug Interaction Group" between March and May 2020 were included. The possible consequences of pDDIs at the QTc interval level or any other adverse event according to the patient's medical record were analysed. A descriptive analysis was carried out to assess possible factors that may affect the QTc interval prolongation. RESULTS AND DISCUSSION: Two hundred and eighteen (62.3%) patients of a total of 350 patients admitted with COVID-19 had at least one pDDI. There were 598 pDDIs. Thirty-eight pDDIs (6.3%) were categorized as not recommended or contraindicated. The mean value difference between baseline and pDDI posterior ECG was 412.3 ms ± 25.8 ms vs. 426.3 ms ± 26.7 ms; p < 0.001. Seven patients (5.7%) had a clinically significant alteration of QTc. A total of 44 non-cardiological events (7.3%) with a possible connection to a pDDI were detected. WHAT IS NEW AND CONCLUSION: The number of pDDIs in patients admitted for COVID-19 in the first pandemic wave was remarkably high. However, clinical consequences occurred in a low percentage of patients. Interactions involving medications that would be contraindicated for concomitant administration are rare. Knowledge of these pDDIs and their consequences could help to establish appropriate therapeutic strategies in patients with COVID-19 or other diseases with these treatments.


Assuntos
Anticorpos Monoclonais Humanizados/efeitos adversos , Tratamento Farmacológico da COVID-19 , Hidroxicloroquina/efeitos adversos , Interferon beta-1b/efeitos adversos , Lopinavir/efeitos adversos , Ritonavir/efeitos adversos , Adjuvantes Imunológicos/efeitos adversos , Idoso , COVID-19/complicações , Estudos de Coortes , Inibidores do Citocromo P-450 CYP3A/efeitos adversos , Interações Medicamentosas , Inibidores Enzimáticos/efeitos adversos , Feminino , Humanos , Masculino , Prevalência , Estudos Retrospectivos , Fatores de Risco , SARS-CoV-2
4.
Farm Hosp ; 45(1): 3-9, 2020 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-33443471

RESUMO

OBJECTIVE: The objective of this study was to assess the results of applying  Lean Methodology in the design of a standardized medication storage model in  hospitalization departments. METHOD: Descriptive and retrospective study conducted between September 2017 and January 2019 in a tertiary level hospital. The Pharmacy Service led the creation of a multidisciplinary team. Lean Methodology was used to establish the components and organization and  identification criteria that made up the standardized medication storage model.  The stocks of each hospitalization department were reviewed and quantified, the final amount of stock needed was agreed with the supervisor of each department, and the economic impact of the implementation of the  standardized medication model was assessed. A questionnaire was designed and sent to nursing staff to determine their level of satisfaction with the new model. RESULTS: The standardized medication storage model was scaled up to 20  nursing departments, leading to an overall reduction of 56.72% in the number of pharmaceutical dosage forms available (5,688 vs 2,462). The number of high-risk drugs was reduced by 40.73% (631 vs 374). This elimination of wastage  achieved a saving of €25,357.98. A total of 58 nurses returned the  questionnaires (20.70% of the total): 22.40% worked a fixed shift and 77.60%  worked a rotating shift. The mean score on overall satisfaction was 5.79 ± 3.61  (scores ranged from 1 to 10). CONCLUSIONS: The application of Lean Methodology is very useful for the  management of medication stocks in hospitalization departments. The implementation of a standardized medication storage model leads to  economic savings and a marked reduction in the number of active ingredients and high-risk medications. The nursing staff were satisfied with the  implementation of the model, suggesting that we should continue to pursue this effective line of action.


Objetivo: El objetivo del estudio es evaluar los resultados de la aplicación de la  metodología Lean en el diseño de un modelo estandarizado de almacenaje de  medicación en las unidades de hospitalización. Método: Estudio descriptivo y  retrospectivo desarrollado entre septiembre de  2017 y enero de 2019 en un  hospital de tercer nivel. Se creó un  equipo multidisciplinar liderado por el  Servicio de Farmacia. Se empleó la  metodología Lean para establecer los  elementos y criterios de organización e identificación que conformaron el modelo estandarizado de almacenaje de  medicación. Se revisaron y cuantificaron los stocks de cada unidad de hospitalización, se consensuó la medicación con la supervisora de cada unidad y se estimó el impacto económico de la implantación del modelo estandarizado. Se diseñó y envió una encuesta para evaluar la  satisfacción de enfermería con el nuevo modelo.Resultados: El modelo estandarizado de almacenaje se aplicó en 20 unidades de enfermería y supuso una reducción global del 56,72% en el número  de presentaciones de principios activos disponibles (5.688 versus 2.462). Se disminuyó el número de presentaciones de principios activos  de medicamentos de alto riesgo en un 40,73% (631 versus 374). La eliminación de este despilfarro supuso un ahorro económico de 25.357,98 €. Se recibieron 58 respuestas a la encuesta de satisfacción del personal de enfermería (20,70%  del total de encuestas enviadas), de las que un 22,40% correspondieron al turno fijo y 77,60% al turno rotativo. La media de la satisfacción global (valorada  entre 1 y 10) fue de 5,79 ± 3,61.Conclusiones: La aplicación de la metodología Lean es útil para la gestión de  stocks de medicación de las unidades de hospitalización. La implantación del  modelo estandarizado de almacenaje conlleva un ahorro económico y una  reducción del número de presentaciones de principios activos y de  medicamentos de alto riesgo. El personal de enfermería está conforme con la  implantación del modelo, lo que nos plantea seguir en esta línea de mejora.


Assuntos
Assistência Farmacêutica , Hospitalização , Humanos , Estudos Retrospectivos , Inquéritos e Questionários , Centros de Atenção Terciária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...